Annual Cash & Cash Equivalents
$19.21 M
-$23.06 M-54.56%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual cash & cash equivalents is $19.21 million, with the most recent change of -$23.06 million (-54.56%) on December 31, 2022.
- During the last 3 years, ELOX annual cash & cash equivalents has fallen by -$3.29 million (-14.61%).
- ELOX annual cash & cash equivalents is now -60.48% below its all-time high of $48.61 million, reached on December 31, 2018.
Performance
ELOX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.78 M
+$444.00 K+10.25%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly cash and cash equivalents is $4.78 million, with the most recent change of +$444.00 thousand (+10.25%) on September 30, 2023.
- Over the past year, ELOX quarterly cash and cash equivalents has dropped by -$19.78 million (-80.55%).
- ELOX quarterly cash and cash equivalents is now -92.47% below its all-time high of $63.41 million, reached on June 30, 2018.
Performance
ELOX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELOX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.6% | -80.5% |
| 3 y3 years | -14.6% | -84.4% |
| 5 y5 years | -20.1% | -90.2% |
ELOX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -88.7% | +10.3% |
| 5 y | 5-year | -54.6% | at low | -91.6% | +10.3% |
| alltime | all time | -60.5% | -100.0% | -92.5% | >+9999.0% |
Eloxx Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $4.78 M(+10.3%) |
| Jun 2023 | - | $4.33 M(-11.7%) |
| Mar 2023 | - | $4.90 M(-74.5%) |
| Dec 2022 | $19.21 M(-54.6%) | $19.21 M(-21.8%) |
| Sep 2022 | - | $24.55 M(-18.3%) |
| Jun 2022 | - | $30.05 M(-24.4%) |
| Mar 2022 | - | $39.77 M(-5.9%) |
| Dec 2021 | $42.27 M(+71.3%) | $42.27 M(-19.4%) |
| Sep 2021 | - | $52.43 M(-7.6%) |
| Jun 2021 | - | $56.73 M(+210.9%) |
| Mar 2021 | - | $18.25 M(-26.0%) |
| Dec 2020 | $24.67 M(+9.7%) | $24.67 M(-19.4%) |
| Sep 2020 | - | $30.59 M(+0.8%) |
| Jun 2020 | - | $30.35 M(+17.3%) |
| Mar 2020 | - | $25.88 M(+15.0%) |
| Dec 2019 | $22.49 M(-53.7%) | $22.49 M(+1.5%) |
| Sep 2019 | - | $22.16 M(-55.1%) |
| Jun 2019 | - | $49.33 M(+10.7%) |
| Mar 2019 | - | $44.58 M(-8.3%) |
| Dec 2018 | $48.61 M(+102.1%) | $48.61 M(-12.2%) |
| Sep 2018 | - | $55.34 M(-12.7%) |
| Jun 2018 | - | $63.41 M(+246.7%) |
| Mar 2018 | - | $18.29 M(+1809.4%) |
| Dec 2017 | $24.05 M(>+9900.0%) | - |
| Sep 2017 | - | $957.90 K(+2785.2%) |
| Jun 2017 | - | $33.20 K(-86.3%) |
| Jun 2017 | $33.20 K(-95.9%) | - |
| Mar 2017 | - | $241.90 K(+62.1%) |
| Dec 2016 | - | $149.20 K(-48.0%) |
| Sep 2016 | - | $287.10 K(-64.6%) |
| Jun 2016 | $810.80 K(-75.7%) | $810.80 K(-46.9%) |
| Mar 2016 | - | $1.53 M(-35.5%) |
| Dec 2015 | - | $2.37 M(-29.5%) |
| Sep 2015 | - | $3.35 M(+0.6%) |
| Jun 2015 | $3.33 M(-45.4%) | $3.33 M(+609.5%) |
| Mar 2015 | - | $470.00 K(-77.7%) |
| Dec 2014 | - | $2.11 M(-45.1%) |
| Sep 2014 | - | $3.84 M(-37.2%) |
| Jun 2014 | $6.11 M(+281.4%) | $6.11 M(-1.4%) |
| Mar 2014 | - | $6.20 M(+1.2%) |
| Dec 2013 | - | $6.12 M(+675.7%) |
| Sep 2013 | - | $789.20 K(-50.7%) |
| Jun 2013 | $1.60 M(-19.9%) | $1.60 M(+1.3%) |
| Mar 2013 | - | $1.58 M(+147.0%) |
| Dec 2012 | - | $640.10 K(-51.2%) |
| Sep 2012 | - | $1.31 M(-34.4%) |
| Jun 2012 | $2.00 M(-44.6%) | $2.00 M(-37.6%) |
| Mar 2012 | - | $3.21 M(+106.5%) |
| Dec 2011 | - | $1.55 M(-45.4%) |
| Sep 2011 | - | $2.84 M(-21.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | $3.61 M(-55.0%) | $3.61 M(-25.7%) |
| Mar 2011 | - | $4.86 M(+0.5%) |
| Dec 2010 | - | $4.84 M(-23.1%) |
| Sep 2010 | - | $6.29 M(-21.6%) |
| Jun 2010 | $8.03 M(+2008.9%) | $8.03 M(>+9900.0%) |
| Mar 2010 | - | $39.70 K(-94.7%) |
| Dec 2009 | - | $751.80 K(+173.1%) |
| Sep 2009 | - | $275.30 K(-27.7%) |
| Jun 2009 | $380.60 K(-93.3%) | $380.60 K(+0.6%) |
| Mar 2009 | - | $378.20 K(-66.1%) |
| Dec 2008 | - | $1.12 M(-54.6%) |
| Sep 2008 | - | $2.46 M(-56.7%) |
| Jun 2008 | $5.68 M(+1291.1%) | $5.68 M(+40.2%) |
| Mar 2008 | - | $4.05 M(-21.2%) |
| Dec 2007 | - | $5.14 M(+213.0%) |
| Sep 2007 | - | $1.64 M(+302.1%) |
| Jun 2007 | $408.10 K(+28.1%) | $408.10 K(-12.1%) |
| Mar 2007 | - | $464.30 K(+22.3%) |
| Dec 2006 | - | $379.60 K(+6.8%) |
| Sep 2006 | - | $355.40 K(+11.6%) |
| Jun 2006 | $318.50 K(+9.1%) | $318.50 K(-28.0%) |
| Mar 2006 | - | $442.50 K(+454.5%) |
| Dec 2005 | - | $79.80 K(-86.3%) |
| Sep 2005 | - | $584.30 K(+100.2%) |
| Jun 2005 | $291.90 K(+56.8%) | $291.90 K(+49.7%) |
| Mar 2005 | - | $195.00 K(-69.5%) |
| Dec 2004 | - | $639.50 K(+436.0%) |
| Sep 2004 | - | $119.30 K(-35.9%) |
| Jun 2004 | $186.20 K(-41.8%) | $186.20 K(-95.0%) |
| Mar 2004 | - | $3.76 M(+1236.8%) |
| Dec 2003 | - | $281.00 K(+0.9%) |
| Sep 2003 | - | $278.50 K(-12.9%) |
| Jun 2003 | $319.90 K(-59.9%) | $319.90 K(+319.8%) |
| Mar 2003 | - | $76.20 K(-82.6%) |
| Dec 2002 | - | $436.80 K(+24.0%) |
| Sep 2002 | - | $352.20 K(-55.9%) |
| Jun 2002 | $798.70 K(+5485.3%) | $798.70 K(-77.1%) |
| Mar 2002 | - | $3.49 M(+23.8%) |
| Dec 2001 | - | $2.82 M(+7272.8%) |
| Sep 2001 | - | $38.20 K(+167.1%) |
| Jun 2001 | $14.30 K(-99.1%) | $14.30 K(-95.6%) |
| Mar 2001 | - | $323.80 K(-47.8%) |
| Dec 2000 | - | $620.10 K(-45.0%) |
| Sep 2000 | - | $1.13 M(-27.5%) |
| Jun 2000 | $1.56 M(+64.3%) | $1.56 M(+928.9%) |
| Mar 2000 | - | $151.20 K(+51.2%) |
| Dec 1999 | - | $100.00 K |
| Jun 1999 | $946.70 K(>+9900.0%) | - |
| Jun 1998 | $0.00(0.0%) | - |
| Jun 1997 | $0.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Eloxx Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Eloxx Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ELOX is $19.21 M
What is the all time high annual cash & cash equivalents for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual cash & cash equivalents is $48.61 M
What is Eloxx Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ELOX annual cash & cash equivalents has changed by -$23.06 M (-54.56%)
What is Eloxx Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELOX is $4.78 M
What is the all time high quarterly cash and cash equivalents for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly cash and cash equivalents is $63.41 M
What is Eloxx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ELOX quarterly cash and cash equivalents has changed by -$19.78 M (-80.55%)